SUNHO BIO-B (02898.HK): Possible delay in publishing 2026 interim results and interim report, trading suspension continues
NewTimeSpace News: On 26 August 2026, Sunho Biologics, Inc. (stock code: 02898) announced that, as the publication of the 2025 annual results is still in progress and the 2026 interim results can only be published after the 2025 annual results, based on the information currently available, the publication of the 2026 interim results is expected to be delayed beyond 31 August 2026, and the board is currently unable to determine the date of the board meeting to approve the publication of the interim results.
The announcement stated that, under Rule 13.49(6) of the Listing Rules, the Company is required to publish its interim results within two months after the end of the six-month period ended 30 June 2026 (i.e. not later than 31 August 2026); under Rule 13.43, an issuer is required to publish an announcement at least seven full business days before the date of the board meeting at which the results for any financial period are approved for publication. As the interim results may be delayed, the interim report, which is required to be published on or before 30 September 2026 under Rule 13.48(1), may also be delayed. The Company will publish further announcements in due course to inform shareholders and potential investors of the date of the board meeting, the date of publication of the 2026 interim results and the date of despatch of the 2026 interim report.
The shares have been suspended from trading on the Stock Exchange since 9:00 a.m. on 1 April 2026 and will remain suspended until the Company has fulfilled all resumption guidance, rectified the issues causing its suspension and fully complied with the Listing Rules to the satisfaction of the Stock Exchange. The Company previously disclosed the resumption guidance set out in the Stock Exchange's letter in an announcement dated 3 May 2026.
NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.
